Y Intercept Hong Kong Ltd Invests $327,000 in Option Care Health, Inc. (NASDAQ:OPCH)

Y Intercept Hong Kong Ltd purchased a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 14,092 shares of the company's stock, valued at approximately $327,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Raymond James & Associates raised its holdings in shares of Option Care Health by 6.3% in the 3rd quarter. Raymond James & Associates now owns 85,279 shares of the company's stock valued at $2,669,000 after buying an additional 5,049 shares during the period. International Assets Investment Management LLC boosted its stake in shares of Option Care Health by 3,029.7% in the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company's stock valued at $91,000 after purchasing an additional 2,757 shares during the period. Wealth Enhancement Advisory Services LLC acquired a new position in shares of Option Care Health in the third quarter valued at approximately $206,000. State of Alaska Department of Revenue increased its stake in Option Care Health by 3.8% during the 3rd quarter. State of Alaska Department of Revenue now owns 19,871 shares of the company's stock worth $621,000 after buying an additional 735 shares during the period. Finally, Nisa Investment Advisors LLC lifted its holdings in Option Care Health by 7.0% during the 3rd quarter. Nisa Investment Advisors LLC now owns 14,526 shares of the company's stock worth $455,000 after buying an additional 945 shares in the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and upped their price target for the stock from $26.00 to $33.00 in a report on Monday, January 13th. UBS Group began coverage on shares of Option Care Health in a report on Thursday, December 5th. They set a "neutral" rating and a $26.00 price target for the company. Barrington Research raised their price objective on shares of Option Care Health from $33.00 to $38.00 and gave the company an "outperform" rating in a report on Thursday, February 27th. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and increased their target price for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $30.00 price objective (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $33.00.

Insider Transactions at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares of the company's stock, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.64% of the company's stock.

Option Care Health Price Performance

OPCH stock traded up $0.17 during trading on Friday, hitting $34.43. The stock had a trading volume of 613,758 shares, compared to its average volume of 1,587,807. The company's 50 day moving average price is $29.61 and its two-hundred day moving average price is $28.18. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock has a market cap of $5.69 billion, a price-to-earnings ratio of 28.93, a price-to-earnings-growth ratio of 2.30 and a beta of 1.33. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $34.85.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.